Industry group despair at 'disproportionate & senseless measures' put on CBD products - Shannett Thompson quoted in Nutraingredients

15 May 2019

Shannett Thompson, Senior Associate in our Regulatory department, was recently quoted in Nutraingredients on regulatory measures taken against CBD-containing products.

“So far as pending authorisations, it is difficult to see how any obstacle to authorisation could prevail on health grounds, given that The World Health Organisation (in a report last June 2018) stated that CBD was generally safe and well tolerated,” 

“This would suggest that the key issue arising in all of this is regulatory compliance, transparency as to methods of production and lawful marketing of such products.” 

About the author

Shannett Thompson is a highly experienced lawyer taking the lead in defending health professionals.  Shannett also has substantial experience in advising individuals in relation to their regulatory obligations in the wider context.

Share insightLinkedIn Twitter Facebook Email to a friend Print

Email this page to a friend

You may also be interested in:

Skip to content Home About Us Insights Services Contact Accessibility